Cargando…

Safety and efficacy of tamsulosin, alfuzosin or silodosin as monotherapy for LUTS in BPH – a double-blind randomized trial

INTRODUCTION: Currently alpha1-adrenoceptor blockers (AB) are widely used as first-line therapy to improve lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). We compared the efficacy and safety profile of tamsulosin, alfuzosin and silodosin in LUTS due to BPH. MA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manohar, Chikka Moga Siddaiah, Nagabhushana, Mahadevappa, Karthikeyan, Vilvapathy Senguttuvan, Sanjay, Ramachandra Pudakalkatti, Kamath, Ananth Janardhan, Keshavamurthy, Ramaiah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Polish Urological Association 2017
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510335/ https://www.ncbi.nlm.nih.gov/pubmed/28721281 http://dx.doi.org/10.5173/ceju.2017.924

Ejemplares similares

Clinical profile and successful outcomes of conservative and minimally invasive treatment of emphysematous pyelonephritis
por: Karthikeyan, Vilvapathy Senguttuvan, et al.
Publicado: (2018)

Incidence of De Novo Erectile Dysfunction after Urethroplasty: A Prospective Observational Study
por: Sachin, Dharwadkar, et al.
Publicado: (2017)

Efficacy of preprocedural diclofenac in men undergoing double J stent removal under local anesthesia: A double-blind, randomized control trial
por: Karthikeyan, Vilvapathy Senguttuvan, et al.
Publicado: (2017)

Tadalafil Alone or in Combination with Tamsulosin for the Management for LUTS/BPH and ED
por: Sebastianelli, A., et al.
Publicado: (2020)

Clinically Meaningful Improvements in LUTS/BPH Severity in Men Treated with Silodosin Plus Hexanic Extract of Serenoa Repens or Silodosin Alone
por: Boeri, Luca, et al.
Publicado: (2017)

A randomized, comparative, open-label study of efficacy and tolerability of alfuzosin, tamsulosin and silodosin in benign prostatic hyperplasia
por: Manjunatha, R., et al.
Publicado: (2016)

Symptomatic and urodynamic responses in patients with reduced or no seminal emission during silodosin treatment for LUTS and BPH
por: Roehrborn, C G, et al.
Publicado: (2011)

Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients
por: Alcaraz, Antonio, et al.
Publicado: (2021)

To compare the efficacy of tamsulosin and alfuzosin as medical expulsive therapy for ureteric stones
por: Singal, Rikki, et al.
Publicado: (2017)

Self-inflicted foreign bodies in lower genitourinary tract in males: Our experience and review of literature
por: Mahadevappa, Nagabhushana, et al.
Publicado: (2016)

PDE5-Is for the Treatment of Concomitant ED and LUTS/BPH
por: Gacci, M., et al.
Publicado: (2013)

Efficacy and safety of tamsulosin vs. alfuzosin as medical expulsive therapy for ureteric stones
por: Ibrahim, Ahmed K., et al.
Publicado: (2013)

Use of α1‐adrenoceptor antagonists tamsulosin and alfuzosin and the risk of Alzheimer's disease
por: Latvala, Laura, et al.
Publicado: (2022)

Complications after prone PCNL in pediatric, adult and geriatric patients – a single center experience over 7 years
por: Kumar, Sumit, et al.
Publicado: (2017)

Impact of early vs. delayed initiation of dutasteride/tamsulosin combination therapy on the risk of acute urinary retention or BPH-related surgery in LUTS/BPH patients with moderate-to-severe symptoms at risk of disease progression
por: D’Agate, Salvatore, et al.
Publicado: (2020)

Clinical Benefit of Tamsulosin and the Hexanic Extract of Serenoa Repens, in Combination or as Monotherapy, in Patients with Moderate/Severe LUTS-BPH: A Subset Analysis of the QUALIPROST Study
por: Alcaraz, Antonio, et al.
Publicado: (2020)

Current consensus and controversies on male LUTS/BPH (part one)
por: Foo, Keong Tatt
Publicado: (2017)

Current consensus and controversies on male LUTS/BPH (part two)
por: Foo, Keong Tatt
Publicado: (2018)

Moving beyond BPH – A contemporary update on male LUTS
por: Chapple, Christopher R.
Publicado: (2019)

Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil
por: Park, Hyun Jun, et al.
Publicado: (2013)

Comparing tamsulosin, silodosin versus silodosin plus tadalafil as medical expulsive therapy for lower ureteric stones: A randomised trial
por: Rahman, Md Jawaid, et al.
Publicado: (2017)

Tamsulosin versus Alfuzosin in the Treatment of Patients with Distal Ureteral Stones: Prospective, Randomized, Comparative Study
por: Ahmed, Abul-fotouh Abdel-maguid, et al.
Publicado: (2010)

Urodynamic profile in posterior urethral valve patients following fulguration: Does age at fulguration matter?
por: Mallya, Ashwin, et al.
Publicado: (2018)

Silodosin vs tamsulosin in the management of distal ureteric stones: A prospective randomised study
por: Elgalaly, Hazem, et al.
Publicado: (2016)

Evaluation of silodosin in comparison to tamsulosin in benign prostatic hyperplasia: A randomized controlled trial
por: Pande, Satabdi, et al.
Publicado: (2014)

Medical Expulsive Therapy for Distal Ureteral Stones: Tamsulosin Versus Silodosin in the Turkish Population
por: Arda, Ersan, et al.
Publicado: (2017)

A Comparison Between Silodosin and Tamsulosin for Medical Expulsive Therapy of Distal Ureteric Calculus
por: Abdullah, Atif, et al.
Publicado: (2023)

Validation of APACHE II scoring system at 24 hours after admission as a prognostic tool in urosepsis: A prospective observational study
por: VijayGanapathy, Sundaramoorthy, et al.
Publicado: (2017)

Tubeless Pediatric Percutaneous Nephrolithotomy: Assessment of Feasibility and Safety
por: Keshavamurthy, Ramaiah, et al.
Publicado: (2018)

Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study
por: Alcaraz, Antonio, et al.
Publicado: (2022)

L.I.F.T. study: Prostatic urethral lift for the treatment of LUTS associated with BPH
por: Gupta, Saurabh
Publicado: (2014)

Current drug therapy of patients with BPH-LUTS with the special emphasis on PDE5 inhibitors
por: Kolontarev, Konstantin, et al.
Publicado: (2016)

Comparison of Tamsulosin and Tadalafil effects in LUTS treatment considering patients' atherosclerosis risk level
por: Tavoosian, Ali, et al.
Publicado: (2022)

Comparison of silodosin to tamsulosin for medical expulsive treatment of ureteral stones: a systematic review and meta-analysis
por: Özsoy, Mehmet, et al.
Publicado: (2016)

Silodosin versus tamsulosin for medical expulsive treatment of ureteral stones: A systematic review and meta-analysis
por: Hsu, Yuan-Pin, et al.
Publicado: (2018)

Is percutaneous nephrolithotomy safe in chronic kidney disease patients!!!
por: Adiga, Pramod, et al.
Publicado: (2022)

The Role of Combination Therapy with α-Blockers and Hexanic Extract of Serenoa repens in the Treatment of LUTS/BPH
por: De Nunzio, Cosimo, et al.
Publicado: (2022)

Effect of estimated prostate volume on silodosin-mediated improvements in the signs and symptoms of BPH: does prostate size matter?
por: Kaplan, Steven A, et al.
Publicado: (2011)

The Effect of Tamsulosin, Dutasteride Monotherapy and Tamsulosin-Dutasteride Combination on Prostate Smooth Muscle Contractility in BPH Model Wistar Strain Rattus Novergicus
por: Daryanto, Besut, et al.
Publicado: (2023)

LUTS/BPH and SARS-COV2: when a misunderstanding in the correct physiopathology results in incorrect associations
por: De Nunzio, Cosimo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5l4q36g7pf1bmjpn3icbc2hijo